Lisa D. Francesco
SVP, Investor Relations and Corporate Communications
Replay available
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) Q1 2025 earnings conference call, held 2025-05-13. Replay captured from the company's public earnings webcast.

SVP, Investor Relations and Corporate Communications
Chief Executive Officer and Director
Senior Vice President and Chief Financial Officer
Senior Vice President and Chief Medical Officer
Analyst, Jefferies
Analyst, Levering Partners
Analyst, Piper Sandler
Analyst, Citigroup
Watch the replay and follow the connected company analysis, news, and investor updates for Lexicon Pharmaceuticals, Inc..
WEBVTT 00:00:00.031 -- 00:00:04.276 Welcome to the Lexicon Pharmaceuticals First Quarter 2025 Financial Results Conference 00:00:04.276 -- 00:00:08.021 Call. At this time, all participants are in not only mode. 00:00:08.021 -- 00:00:12.247 Following management's prepared remarks, we will hold a brief question and answer session. 00:00:12.247 -- 00:00:15.351 As a reminder, this call is being recorded today, May 13, 2025. 00:00:15.351 -- 00:00:20.257 I will now turn the call over to Lisa D. Francesco, SVP, Investor Relations and Corporate 00:00:20.257 -- 00:00:24.320 Communications for Lexicon. Please go ahead, Lisa. 00:00:25.124 -- 00:00:29.050 Thank you, Shannon. Good afternoon and welcome to the Lexicon Pharmaceuticals First Quarter 00:00:29.050 -- 00:00:33.618 2025 Financial Results Conference Call. Joining me today are Dr. 00:00:33.618 -- 00:00:38.686 Mike Exton, Lexicon's Chief Executive Officer and Director, and Scott Chianti, Senior 00:00:38.686 -- 00:00:41.070 Vice President and Chief Financial Officer. 00:00:41.070 -- 00:00:44.636 Dr. Craig Granowitz, Senior Vice President and Chief Medical Officer, will join us for 00:00:44.636 -- 00:00:49.263 Q&A. Earlier this afternoon, Lexicon issued a press release announcing our financial 00:00:49.263 -- 00:00:52.175 results for the first quarter of 2025. 00:00:52.175 -- 00:00:55.659 which is available on our website at www.lexpharma.com 00:00:55.659 -- 00:01:00.365 and through our SEC filing. A webcast of this call, along with a slide presentation, 00:01:00.365 -- 00:01:04.730 is also available on our website. During this call, we will review the information provided 00:01:04.730 -- 00:01:08.114 in the release, provide a corporate update, and then use the remainder of our time to 00:01:08.114 -- 00:01:10.236 answer you...